Cleared Traditional

K900322 - CO/CMD-1

K900322 is an FDA 510(k) clearance for CO/CMD-1, manufactured by Spirometrics, Inc.. The device is a Class 2 Anesthesiology device with product code CCJ cleared through the Traditional 510(k) pathway after a 97-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1990
Decision
97d
Days
Class 2
Risk

K900322 is an FDA 510(k) clearance for the CO/CMD-1. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Spirometrics, Inc. (Auburn, US). The FDA issued a Cleared decision on April 30, 1990 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K900322

510(k) Number K900322 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 1990
Decision Date April 30, 1990
Days to Decision 97 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 140d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCJ Device Classification - Class 2, Special Controls

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 27
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K900322.
CO BREATH ANALYSIS MODULE & MONOXOL II
K952694 · Bacharach, Inc. · Jan 1996
SPIROLOOP, MODIFICATION
K904633 · Pneumedics, Inc. · Mar 1991
VITALOGRAPH - BREATHCO MONITOR
K902113 · Mcneill Intl., Inc. · Oct 1990
BEDFONT EC50 SMOKERLYZER CARBON MONOXIDE MONITOR
K892841 · Bedfont Technical Instruments , Ltd. · Oct 1989
VITALOGRAPH-BREATHCO MONITOR
K892524 · Vitalograph , Ltd. · May 1989
VITALOGRAPH EC-50 CARBON MONOXIDE MONITOR
K863420 · Vitalograph , Ltd. · Jan 1987